Meridian Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $579K | Buy |
4,576
+233
| +5% | +$29.5K | 0.02% | 412 |
|
|
2025
Q1 | $555K | Sell |
4,343
-299
| -6% | -$38.2K | 0.03% | 391 |
|
|
2024
Q4 | $614K | Sell |
4,642
-62
| -1% | -$8.2K | 0.03% | 374 |
|
|
2024
Q3 | $685K | Buy |
+4,704
| New | +$685K | 0.03% | 353 |
|
|
2024
Q2 | – | Sell |
-4,939
| Closed | -$678K | – | 391 |
|
|
2024
Q1 | $678K | Sell |
4,939
-91
| -2% | -$12.5K | 0.11% | 119 |
|
|
2023
Q4 | $683K | Sell |
5,030
-5,124
| -50% | -$696K | 0.04% | 323 |
|
|
2023
Q3 | $1.24M | Buy |
10,154
+4,242
| +72% | +$519K | 0.08% | 208 |
|
|
2023
Q2 | $751K | Buy |
5,912
+8
| +0.1% | +$1.02K | 0.06% | 247 |
|
|
2023
Q1 | $763K | Buy |
5,904
+43
| +0.7% | +$5.55K | 0.07% | 251 |
|
|
2022
Q4 | $769K | Buy |
5,861
+45
| +0.8% | +$5.91K | 0.08% | 234 |
|
|
2022
Q3 | $680K | Buy |
5,816
+126
| +2% | +$14.7K | 0.07% | 234 |
|
|
2022
Q2 | $669K | Buy |
5,690
+445
| +8% | +$52.3K | 0.05% | 291 |
|
|
2022
Q1 | $683K | Hold |
5,245
| – | – | 0.07% | 198 |
|
|
2021
Q4 | $800K | Hold |
5,245
| – | – | 0.09% | 184 |
|
|
2021
Q3 | $848K | Hold |
5,245
| – | – | 0.1% | 165 |
|
|
2021
Q2 | $858K | Buy |
5,245
+166
| +3% | +$27.2K | 0.11% | 158 |
|
|
2021
Q1 | $765K | Sell |
5,079
-55
| -1% | -$8.28K | 0.11% | 160 |
|
|
2020
Q4 | $777K | Buy |
+5,134
| New | +$777K | 0.12% | 143 |
|
|
2019
Q3 | – | Sell |
-317
| Closed | -$346 | – | 312 |
|
|
2019
Q2 | $346 | Buy |
+317
| New | +$346 | 0.01% | 434 |
|